Dai Dipartimenti di Medicina (F. Lamontagne, M.-CB, HQM) e Anestesiologia (FD), Università di Sherbrooke, Dipartimento di Farmacia (BB), Centre de Recherche du CHU de Sherbrooke, Centre Intégré Universitaire de Santé et de Services Sociaux de l’Estrie Centre Hospitalier Universitaire de Sherbrooke (F. Lamontagne, M.-HM, JM, FD, E. Carbonneau), Bishop University (DC), Sherbrooke, QC, Dipartimento di Ortopedia, Dipartimento di Chirurgia (SS), Dipartimento di Medicina (DJC, GHG, BR, TM, MOM, EPB-C., SSK), Department of Health Research Methods, Evidence, and Impact (DJC, GHG, BR, MOM, LH, EPB-C. and Respiratory Therapy , Hamilton Health Sciences (LH), Hamilton, Ontario, Dipartimento di medicina di terapia intensiva, Sunnybrook Health Sciences Center (R. Pinto, NM, NKJA), t è il dipartimento interdipartimentale di medicina di terapia intensiva, Università di Toronto (SM, NKJA) e Sinai Health System (SM), Toronto, Departments of Medicine Critical Care (DKH, DMM, MH), Public Health Sciences (AGD) e Medicine (DMM), Queen’s University, Kingston Health Sciences Center (AGD, DMM), Kingston, Ontario, Dipartimento di Farmacia, Ottawa Hospital (SK), Research Institute Ottawa Hospital (SK, IW, R. Porteous) e Dipartimento di Chirurgia, Università di Ottawa (AJES), Ottawa, Ontario, Masaope Valley Foundation, Air Cliff, QC (DC), Dipartimento di Medicina, Università di Montreal (MC), Ospedale dell’Università di Montreal Centre (MC), ML, E. Charbonney), il Centre de Recherche de l’Hôpital du Sacré-Coeur de Montréal (E. Charbonney) e i dipartimenti di medicina e terapia intensiva, McGill University Health Center (JS), Montreal, QC, Dipartimento di medicina (F. Lauzier) e Dipartimento di medicina intensiva, Dipartimento di anestesiologia e terapia intensiva (F. Lauzier, AFT), University of Laval, and Care Medicine Service Critical Care (F. Lauzier, AFT), Research Center (F. Lauzier, AFT), CHU de Québec-Université Laval, Quebec, QC, Department of Critical Care Medicine, University of Alberta, Edmonton (OGR, DJK), Dipartimento di terapia intensiva, Divisione di medicina, CHU Dr. University of London, Ontario (TSM), Department of Intensive Care Medicine, Island Health Authority, Victoria, British Columbia (GW) e Department of Medicine, Halton Healthcare, Oakville, Ontario (SSK) – tutti in Canada; Unità di terapia intensiva cardiovascolare, Auckland City Hospital (R. Parke, SPM), School of Nursing, University of Auckland (R. Parke), Auckland, New Zealand Medical Research Institute, Newtown (R. Parke, SPM, PJY) e Care Unit Intensive, Wellington Hospital, Wellington (PJY) e Department of Surgical Sciences, University of Otago, Dunedin (PT) – tutti in Nuova Zelanda; Department of Critical Care Medicine, Apollo Hospitals, Chennai e George Institute of Global Health, Nuova Delhi – entrambi in India (BKTV); Dipartimento di Terapia Intensiva, Ospedale Raymond-Poincaré (Assistance Publique – Hôpitaux de Paris [AP-HP]), la Fédération Hospitalo-Universitaire SEPSIS, Garches (DA), Institut National de la Santé et de la Recherche Médicale, University Paris-Sclay Campus UVSQ, Versailles (DA), e Service de Médecine Intensive Réanimation, AP-HP, Hôpitaux Hepitaux Universitaire -Mondor, Groupe de Recherche Clinique CARMAS e Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, Créteil (AM-D.) – tutti in Francia; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Center for Medical Research e Intensive Care Department, King Abdulaziz Medical City, Ministero degli affari sanitari della Guardia Nazionale – tutti a Riyadh, Arabia Saudita (YMA); Centro di ricerca sulla terapia intensiva dell’Australia e della Nuova Zelanda, Monash University, Melbourne, VIC, Australia (R. Parke, SPM, PJY).